Tracey Sacco
Corporate Officer/Principal presso SCHOLAR ROCK HOLDING CORPORATION
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Tracey Sacco
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 06/02/2023 | - |
Storia della carriera di Tracey Sacco
Precedenti posizioni note di Tracey Sacco
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACCELERON PHARMA INC. | Vendite & Marketing | 01/01/2012 | 01/09/2021 |
Formazione di Tracey Sacco
| Boston College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Borsa valori
- Insiders
- Tracey Sacco
- Esperienza
